Now Available!|Research-Grade ActCel T Cell Activation Reagent – Free Trials for New Product
T cells are an elite force within our immune system, and T cell therapy is demonstrating significant potential in tackling challenging diseases like cancer and autoimmune disorders, offering new treatment options for more patients. Within T cell therapy, T cell activation is an essential step with a direct impact on treatment efficacy. If the activation intensity is too low, T cell transduction efficiency may decrease, impairing its antitumor effect. Conversely, excessive activation can lead to T cell exhaustion, compromising their persistence and function. Therefore, selecting an appropriate T cell activation reagent is crucial.
Typically, the CAR-T process includes steps such as patient blood collection, T cell isolation, T cell activation, transduction, expansion, and reinfusion. Among these, T cell activation is a critical step that not only influences subsequent cell proliferation but also directly affects the efficacy and persistence of CAR-T cell therapy. One of the most widely used strategies for T cell activation is to use CD3/CD28 antibody-coupled microbeads or nanoparticles, providing the necessary first and second signals required for T cell activation and proliferation. Nanoparticle-based reagents, with their ultra-fine particle size, remain evenly dispersed in the culture medium without sedimentation, offering uniform contact and activation of T cells, and require no pre-washing, making them easy to use. These advantages make nano-based T cell activation reagents an attractive option for CAR-T therapy.
New Product Launch with Free Trial Opportunity
The research-grade ActCel T Cell Activation Reagent (Cat.No.TL-6001-1000), produced using advanced nano-magnetic bead technology, is coupled with anti-human CD3 and CD28 antibodies on a nano matrix. This reagent enables gentle and efficient activation of T cells, maintaining high viability and proliferation, making it an optimal choice for ex vivo T cell activation.
Product Highlights
01 Safe and Efficient: Provides gentle stimulation for T cell activation and proliferation
02 User-Friendly:Ready-to-use, directly applicable
03 Cost-Effective: Stable performance at a competitive price
Product Information
Product Performance
Interested in trying our new ActCel T Cell Activation Reagent?
Contact us today to request a free sample and experience the benefits firsthand for your research!
T&L Biotechnology Co., Ltd. focuses on the research and development of upstream, GMP-grade raw materials and reagents for cell and gene therapy (CGT). We are committed to providing total solutions for CGT customers through our comprehensive product and service offerings. Our products include cell separation and activation magnetic beads, eukaryotic/prokaryotic recombinant proteins, serum-free medium, cell culture kits, and more.
We operate a research and development laboratory and a 3,200-square-meter GMP-level clean workshop. These facilities include platforms for cell separation magnetic bead development, eukaryotic and prokaryotic protein expression engineering, and serum-free medium development. We adhere to both the ISO 13485 and ISO 9001 Quality Management System Standards. Additionally, some of our products have FDA DMF filings.